Professional Summary
Professional Overview
Denis Bronnikov is a seasoned business development executive with extensive experience in the biotechnology and life sciences industries. As the Vice President of Business Development at 4D Molecular Therapeutics, he leverages his deep expertise in strategy, operations, and partnerships to drive the company's growth and impact.
Experience Summary
Current Role
As the Vice President of Business Development at 4D Molecular Therapeutics, Denis is responsible for leading the company's strategic initiatives, identifying and securing new business opportunities, and forging strategic partnerships that accelerate the development and commercialization of innovative gene therapy solutions. He has been instrumental in shaping the company's business development strategy, which has resulted in several high-profile collaborations and increased the visibility of 4D Molecular Therapeutics in the industry.
Career Progression
Prior to his current role, Denis held various leadership positions in business development and strategy at renowned companies such as Synthego Corporation, CareDx, Inc., Rewrite Therapeutics, Berkeley Lights, Inc., Roche, and Novartis. Throughout his career, he has demonstrated a strong track record of successfully negotiating and executing strategic partnerships, driving business growth, and contributing to the development of cutting-edge technologies and therapies.
Academic Background
Denis holds a Master of Business Administration (MBA) from IMD, one of the world's leading business schools. He also earned a Ph.D. in Molecular Biology from the University of California, Los Angeles (UCLA), David Geffen School of Medicine, where he conducted groundbreaking research and published numerous peer-reviewed articles.
Areas of Expertise
- Business development and strategic partnerships
- Biotechnology and life sciences industry
- Gene therapy and molecular therapeutics
- Market analysis and strategic planning
- Operational excellence and process optimization
- Cross-functional leadership and collaboration
Professional Impact
During his tenure, Denis has played a pivotal role in securing several high-profile collaborations and partnerships that have expanded the reach and impact of the companies he has served. His strategic vision, industry expertise, and ability to forge successful partnerships have been instrumental in driving the growth and success of these organizations.
Conclusion
With his extensive experience, deep industry knowledge, and proven track record of driving business development initiatives, Denis Bronnikov is poised to continue making a significant impact in the biotechnology and life sciences industry. His commitment to innovation, strategic thinking, and collaborative leadership make him a valuable asset to 4D Molecular Therapeutics and its partners as they work to advance the field of gene therapy.
